FORTIS HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 465.8 INR | +4.37% |
|
-1.96% | +11.12% |
| 05-27 | Jefferies Adjusts Fortis Healthcare’s Price Target to INR545 From INR510, Keeps at Buy | MT |
| 05-24 | Fortis Healthcare's Consolidated Net Profit Rises in Fiscal Q4 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 | 68.93B 825M 64.9B | Sales 2025 * | 78.94B 945M 74.33B | Capitalization | 352B 4.21B 331B |
|---|---|---|---|---|---|
| Net income 2024 | 6.01B 71.99M 5.66B | Net income 2025 * | 8.24B 98.66M 7.76B | EV / Sales 2024 | 4.6 x |
| Net Debt 2024 * | 2.2B 26.29M 2.07B | Net Debt 2025 * | 814M 9.75M 766M | EV / Sales 2025 * | 4.46 x |
| P/E ratio 2024 |
53
x | P/E ratio 2025 * |
42.7
x | Employees | 13,010 |
| Yield 2024 * |
0.22% | Yield 2025 * |
0.26% | Free-Float | 64.76% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fortis Healthcare Limited
More recommendations
More press releases
| 1 day | +4.37% | ||
| 1 week | -1.96% | ||
| Current month | -1.96% | ||
| 1 month | +2.71% | ||
| 3 months | +17.23% | ||
| 6 months | +20.81% | ||
| Current year | +11.12% |
1 week
406.00
489.00
1 month
406.00489.00
Current year
375.05489.00
1 year
279.65489.00
3 years
219.75489.00
5 years
111.30489.00
10 years
100.25489.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 18/03/19 | |
Daljit Singh
PSD | President | 71 | 31/08/02 |
| Director of Finance/CFO | - | 07/04/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mehmet Aydinlar
BRD | Director/Board Member | 67 | 27/03/23 |
| Director/Board Member | 68 | 26/04/18 | |
Prem Kumar Nair
BRD | Director/Board Member | 64 | 11-09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.25% | 6 M€ | +6.07% | - | |
| 0.03% | 4 M€ | -4.41% | - | |
| 0.02% | 114 M€ | +4.36% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/06/24 | 465.8 | +4.37% | 1,576,892 |
| 06/06/24 | 446.3 | +0.69% | 1,305,847 |
| 05/06/24 | 443.2 | +0.89% | 2,323,667 |
| 04/06/24 | 439.4 | -4.35% | 1,061,126 |
| 03/06/24 | 459.4 | -3.32% | 1,476,514 |
Delayed Quote NSE India S.E., June 07, 2024 at 12:58 pm
More quotes
Fortis Healthcare Limited is an India-based integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company operates through healthcare services segment. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. It manages and operates a network of multi-specialty hospitals and diagnostics centers. The healthcare verticals of the Company primarily consist of hospitals, diagnostics, and day care specialty facilities. It has approximately 27 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, United Arab Emirates and Sri Lanka. Its subsidiaries include Escorts Heart Institute and Research Centre Limited, Fortis Health staff Limited, and Fortis Asia Healthcare Pte. Ltd, among others.
Calendar
07/08/2024
- Q1 2025 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
465.8
INR
Average target price
506.1
INR
Spread / Average Target
+8.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.12% | 4.04B | |
| -25.47% | 15B | |
| -1.80% | 11.99B | |
| +3.48% | 11.7B | |
| +27.17% | 8.59B | |
| -6.29% | 7.5B | |
| +6.08% | 6.71B | |
| +0.89% | 6.02B | |
| -4.31% | 4.28B | |
| -10.93% | 3.97B |
- Stock Market
- Equities
- FORTIS Stock